The (S,R,S)-AHPC-Me-C7 ester is primarily utilized in the field of targeted protein degradation, particularly in the development of PROTACs (Proteolysis Targeting Chimeras). These molecules are designed to selectively degrade disease-causing proteins by recruiting them to the ubiquitin-proteasome system for destruction. This specific ester is often employed as a linker or a component in the synthesis of PROTACs, enhancing their stability and efficacy. Its application is significant in cancer research, where it aids in the degradation of oncogenic proteins, offering a promising therapeutic strategy. Additionally, it is explored in neurodegenerative disease studies to target and eliminate misfolded proteins. The compound’s role in advancing precision medicine underscores its importance in modern drug discovery and development.